Table 5.

Adjusted effect sizes (OR) with 95% CIs of risk factors for COVID-19 hospital mortality

Diagnosis (group)	Adjusted OR (95% CI) (all)	Adjusted OR (95% CI) (male)	Adjusted OR (95% CI) (female)
Hemiplegia or paraplegia	1.51 (1.21–1.89)***	1.51 (1.15–1.99)***	1.51 (1.03–2.20)**
Renal disease	1.51 (1.42–1.61)***	1.42 (1.31–1.55)***	1.62 (1.48–1.79)***
Chronic obstructive pulmonary disease	1.51 (1.41–1.61)***	1.50 (1.38–1.63)***	1.53 (1.38–1.70)***
Moderate or severe liver disease	1.49 (1.14–1.94)***	1.54 (1.12–2.12)***	1.49 (0.91–2.44)
Dementia	1.49 (1.38–1.60)***	1.63 (1.46–1.81)***	1.36 (1.22–1.51)***
Diabetes without complications	1.48 (1.39–1.58)***	1.35 (1.24–1.46)***	1.72 (1.56–1.89)***
Diabetes with complications	1.47 (1.35–1.61)***	1.58 (1.41–1.77)***	1.32 (1.14–1.53)***
Rheumatoid disease	1.44 (1.23–1.68)***	1.20 (0.93–1.54)	1.60 (1.31–1.95)***
Congestive heart failure	1.37 (1.28–1.46)***	1.35 (1.24–1.48)***	1.39 (1.26–1.53)***
Mild liver disease	1.30 (1.19–1.43)***	1.25 (1.11–1.41)***	1.39 (1.20–1.61)***
Peripheral vascular disease	1.23 (1.15–1.32)***	1.23 (1.13–1.34)***	1.25 (1.11–1.40)***
AIDS/HIV	1.17 (0.30–4.50)	1.03 (0.20–5.20)	1.73 (0.15–19.30)
Cerebrovascular disease	1.14 (1.07–1.22)***	1.15 (1.06–1.25)***	1.13 (1.02–1.24)**
Peptic ulcer disease	1.09 (0.92–1.28)	1.04 (0.84–1.28)	1.17 (0.90–1.51)
Cancer (any malignancy)	1.07 (1.00–1.15)*	1.00 (0.91–1.09)	1.23 (1.09–1.39)***
Metastatic solid tumour	1.07 (0.91–1.26)	0.97 (0.79–1.20)	1.24 (0.95–1.62)
Acute myocardial infarction	1.03 (0.93–1.14)	1.03 (0.90–1.17)	1.04 (0.87–1.24)
Total number of observations	56,280	32,250	24,030

Authors’ calculation based on [16, 17]

*, **, *** refer to significance at the p < 0.10, p < 0.05, and p < 0.01 level, respectively. Results refer to odds ratios (OR) and 95% confidence intervals (95% CI) obtained from logistic regression; analyses were adjusted for age group, sex and health care region